Detalles de la búsqueda
1.
A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma.
Jpn J Clin Oncol
; 54(4): 444-451, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271157
2.
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.
Cancer Sci
; 112(6): 2426-2435, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792128
3.
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Cancer Sci
; 112(5): 1943-1954, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33576088
4.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Haematologica
; 105(9): 2308-2315, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054055
5.
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.
Am J Hematol
; 90(9): 819-24, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26103598
6.
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
Am J Hematol
; 90(4): 282-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25530131
7.
[Diffuse large B-cell lymphoma of the testis relapsed 16 years after achieving complete response].
Rinsho Ketsueki
; 56(12): 2447-51, 2015 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-26725353
8.
Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.
Haematologica
; 99(12): 1817-25, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25216682
9.
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
NPJ Syst Biol Appl
; 8(1): 39, 2022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229495
10.
Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: a multicenter phase II study.
Cancer Sci
; 102(9): 1698-705, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21645173
11.
Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.
Cancer Sci
; 101(12): 2579-85, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20942866
12.
Reactive lymphoid hyperplasia with giant follicles associated with a posttherapeutic state of hematological malignancies. A report of eight cases.
Tumori
; 96(1): 143-8, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20437872
13.
Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group.
Int J Hematol
; 111(3): 401-408, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31894533
14.
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5 ): The phase 2, multicenter N-Road study.
Cancer Med
; 9(11): 3742-3751, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253827
15.
Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice.
Cancer Sci
; 100(1): 144-9, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19018756
16.
Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan.
In Vivo
; 33(4): 1355-1362, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31280230
17.
Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.
Cancer Sci
; 99(1): 145-51, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17970786
18.
Lymphoplasmacytic infiltrate of regional lymph nodes in Kuttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases.
Int J Surg Pathol
; 16(3): 263-8, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18573783
19.
Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14).
Leuk Lymphoma
; 59(7): 1606-1613, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29081255
20.
Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study.
Int J Hematol
; 108(5): 564, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30168086